Short answer
When designing medical technologies for global health challenges like cancer, prioritize affordability, accessibility, and adaptability to diverse economic and healthcare infrastructures, especially for less developed regions.
- Field
- Commercial Production
- Source
- CA A Cancer Journal for Clinicians (2015)
- Method
- Statistical analysis of GLOBOCAN estimates.
- Evidence
- Strong effect
The rising global incidence and mortality of cancer, particularly in less developed countries, necessitates the commercial production of innovative, cost-effective, and regionally appropriate medical technologies and services. This commercial production research insight is drawn from a 2015 study published in CA A Cancer Journal for Clinicians. Using Statistical analysis of globocan estimates., researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing medical technologies for global health challenges like cancer, prioritize affordability, accessibility, and adaptability to diverse economic and healthcare infrastructures, especially for less developed regions.
Global cancer burden increases demand for accessible and affordable diagnostic and treatment technologies
The rising global incidence and mortality of cancer, particularly in less developed countries, necessitates the commercial production of innovative, cost-effective, and regionally appropriate medical technologies and services.
CA A Cancer Journal for Clinicians · 2015
Key Findings
- 01Approximately 14.1 million new cancer cases and 8.2 million deaths occurred worldwide in 2012.
- 02Less developed countries account for about 57% of cases and 65% of cancer deaths globally.
- 03Lung cancer is the leading cause of cancer death among males globally and has surpassed breast cancer for females in more developed countries.
- 04Disparities in mortality rates between more and less developed countries reflect differences in cancer mix, risk factors, detection practices, and treatment availability.
- 05A substantial portion of cancer cases and deaths could be prevented through effective prevention measures.
Application
Design takeaway
When designing medical technologies for global health challenges like cancer, prioritize affordability, accessibility, and adaptability to diverse economic and healthcare infrastructures, especially for less developed regions.
How to apply
A design team developing a new cancer diagnostic device should conduct market research in both developed and less developed countries to understand specific needs, cost constraints, and infrastructure limitations, informing material selection, manufacturing processes, and distribution strategies.
Project actions
- 01When designing a medical product, consider the global market and how your product could be made affordable and accessible to people in different economic situations.
- 02Research existing low-cost manufacturing techniques that could be applied to medical device production to reduce costs without sacrificing quality.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Comprehensive global overview of cancer burden.
- +Highlights disparities between developed and less developed countries.
- +Identifies key risk factors and prevention opportunities.
Limitations
This data is from 2012, so the exact numbers might be different now. It doesn't tell us exactly what kind of medical devices are needed, just that there's a big problem to solve.
Reliability & validity
The study uses GLOBOCAN data, which is a respected source for global cancer statistics, contributing to its reliability. Validity is supported by the comprehensive nature of the data collection and the clear definitions of incidence and mortality. However, data collection methods can vary between countries, potentially affecting the precision of some estimates.
Think critically
How might intellectual property laws and patent protections impact the commercial production and accessibility of life-saving cancer treatments in less developed countries?
Design Principles
"Global Health Equity through Design: Design and produce solutions that address health disparities by being affordable, accessible, and culturally appropriate for all populations."
This insight highlights the critical role of commercial production in addressing global health challenges. Designers must consider market needs, resource allocation, and ethical production practices to deliver solutions that are both effective and accessible, especially in diverse economic contexts.
What This Means for Your Design
More people are getting cancer, especially in poorer countries, which means we need to design and make medical tools and treatments that are cheap and easy for everyone to get, not just rich countries.
How to use in your project
- 1.When discussing the target market for a medical product, reference the global cancer burden to justify the need for accessible solutions.
- 2.In the 'Commercial Production' section, explain how manufacturing choices (e.g., lean production, choice of materials) can impact the affordability and availability of your product in diverse markets, linking it to global health disparities.
Add to My Project
Quick Cite
Paragraph starter
The 2015 study by Torre et al. on global cancer statistics revealed a significant and increasing burden of cancer, with 14.1 million new cases and 8.2 million deaths worldwide in 2012. Crucially, less developed countries accounted for a disproportionate 57% of cases and 65% of deaths, highlighting a critical need for accessible and affordable healthcare solutions. This disparity underscores the importance of commercial production strategies that prioritize cost-effectiveness, regional adaptability, and widespread distribution to address global health inequities in cancer diagnosis and treatment.
Source
Questions About This Research
- What does the research say about global cancer burden increases demand for accessible and affordable diagnostic and treatment technologies?
- When designing medical technologies for global health challenges like cancer, prioritize affordability, accessibility, and adaptability to diverse economic and healthcare infrastructures, especially for less developed regions. Evidence: CA A Cancer Journal for Clinicians (2015).
- Why does "Global cancer burden increases demand for accessible and affordable diagnostic and treatment technologies" matter for design?
- This insight highlights the critical role of commercial production in addressing global health challenges. Designers must consider market needs, resource allocation, and ethical production practices to deliver solutions that are both effective and accessible, especially in diverse economic contexts.
- How can designers apply this research?
- When designing medical technologies for global health challenges like cancer, prioritize affordability, accessibility, and adaptability to diverse economic and healthcare infrastructures, especially for less developed regions.
- What were the main findings?
- Approximately 14.1 million new cancer cases and 8.2 million deaths occurred worldwide in 2012.. Less developed countries account for about 57% of cases and 65% of cancer deaths globally.. Lung cancer is the leading cause of cancer death among males globally and has surpassed breast cancer for females in more developed countries.. Disparities in mortality rates between more and less developed countries reflect differences in cancer mix, risk factors, detection practices, and treatment availability.
- What research method was used?
- Statistical analysis of GLOBOCAN estimates..
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2015 journal from CA A Cancer Journal for Clinicians.
- What should I do differently in my next project?
- A design team developing a new cancer diagnostic device should conduct market research in both developed and less developed countries to understand specific needs, cost constraints, and infrastructure limitations, informing material selection, manufacturing processes, and distribution strategies.
- What are the limitations?
- The study uses 2012 data, so current figures may have changed. It provides broad statistical overview rather than specific design solutions or market analyses for medical devices.